BLACKLEDGER Buying Watch: VGZ, CIFR, EUR/USD
BLACKLEDGER's latest buying watch update tracks VGZ, CIFR, EUR/USD, USD/CHF, DNN, VKTX from the active public watchlist. This post is built from public-safe status data, in-house public signal labels, and outside public source context. It is designed to help readers understand what is happening around each asset without exposing private research methods.
Buying Watch Data
The dedicated feed category for this update is Buying. The latest public scan timestamp is 2026-09-02T08:00:55.297842+00:00.
- VGZ (stock): Bull public bias, Extended, public score 8.3/10, status: Paper trading research.
- CIFR (stock): Bull public bias, Extended, public score 8.3/10, status: Paper trading research.
- EUR/USD (forex): Bull public bias, Extended, public score 8.3/10, status: Paper trading research.
- USD/CHF (forex): Bull public bias, Extended, public score 8.3/10, status: Paper trading research.
- DNN (stock): Bull public bias, A-List, public score 7.5/10, status: Paper trading research.
- VKTX (stock): Bull public bias, A-List, public score 7.5/10, status: Paper trading research.
- DOGE (crypto): Bull public bias, A-List, public score 7.5/10, status: Paper trading research.
- ABOS (stock): Bull public bias, A-List, public score 6.8/10, status: Paper trading research.
Educational Context: How To Use This Page
This page is not a trade instruction. It is an educational research brief. Readers can use it to understand company or project background, public market context, public status labels, and relevant outside-source headlines before doing their own due diligence.
VGZ Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: Vista Gold Corp.. Market class: stock. Public bias: Bull. Public tier: Extended.
Vista Gold Corp., together with its subsidiaries, operates as a development-stage company in the gold mining industry. Its flagship asset is the 100% owned Mt Todd gold project located in the Northern Territory, Australia. The company was formerly known as Granges, Inc. and changed its name to Vista Gold Corp. in November 1996. Vista Gold Corp. was incorporated in 1983 and is based in Englewood, Colorado.
- Latest public price/reference: $2.1
- Public market capitalization: not available
- Recent public volume/reference: 782.56K
- One-month public movement: 20.69%
- Sector/category: Basic Materials
Why VGZ Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bull. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Vista Gold Q2 Earnings Call Highlights — MarketBeat
- A gold developer moves to actively preparing for production — InvestorsHub
- Vista Gold Corp. (VGZ) Strengthens Leadership Team to Accelerate Mt Todd Project Development — Insider Monkey
- Vista Gold Corp (VGZ) Q1 2026 Earnings Call Highlights: Strong Financial Position Amid ... — GuruFocus.com
CIFR Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: Cipher Digital Inc.. Market class: stock. Public bias: Bull. Public tier: Extended.
Cipher Digital Inc., together with its subsidiaries, develops and operates industrial-scale data centers for bitcoin mining and high-performance compute (HPC) hosting in the United States. It develops HPC data center facilities across various sites for hyperscaler tenants; operates power at one bitcoin mining data center; and maintains a pipeline across various sites. The company was formerly known as Cipher Mining Inc. and change its name to Cipher Digital Inc. in February 2026. The company was founded in 2021 and is headquartered in New York, New York.
- Latest public price/reference: $14.61
- Public market capitalization: $6.06B
- Recent public volume/reference: 19.90M
- One-month public movement: -40.27%
- Sector/category: Technology
Why CIFR Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bull. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Applied Digital Drops 4% as Rising Yields Hit AI Infrastructure, Cipher Mining Sinks 6%, Core Scientific Slides 3% — 24/7 Wall St.
- IREN, CIFR, HUT Stock Price Updates, PUCT Approves Permian Basin Transmission Line, SpaceX’s Turbine Fabrication — Blockspace
- IREN vs. CIFR: Which Bitcoin Miner Is the Better AI Play? — Zacks
- Zacks Investment Ideas feature highlights: QQQ, NVIDIA, CoreWeave, Nebius, TeraWulf, Cipher and IREN — Zacks
EUR/USD Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: EUR/USD. Market class: forex. Public bias: Bull. Public tier: Extended.
Outside-source profile data was limited for this asset at publication time, so this section focuses on public BLACKLEDGER status data and verified public market context.
- Latest public price/reference: not available
- Public market capitalization: not available
- Recent public volume/reference: not available
- One-month public movement: not available
- Sector/category: not available
Why EUR/USD Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bull. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- No fresh public headlines were available from the automated outside-source pull. The asset r[redacted]ins covered through public status data.
USD/CHF Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: USD/CHF. Market class: forex. Public bias: Bull. Public tier: Extended.
Outside-source profile data was limited for this asset at publication time, so this section focuses on public BLACKLEDGER status data and verified public market context.
- Latest public price/reference: not available
- Public market capitalization: not available
- Recent public volume/reference: not available
- One-month public movement: not available
- Sector/category: not available
Why USD/CHF Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bull. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- No fresh public headlines were available from the automated outside-source pull. The asset r[redacted]ins covered through public status data.
DNN Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: Denison Mines Corp.. Market class: stock. Public bias: Bull. Public tier: A-List.
Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. It holds 95% interest in its flagship project Wheeler River uranium project located in the Athabasca Basin region in northern Saskatchewan. The company was formerly known as International Uranium Corporation and changed its name to Denison Mines Corp. in December 2006. The company was founded in 1954 and is headquartered in Toronto, Canada.
- Latest public price/reference: $3.2
- Public market capitalization: $2.90B
- Recent public volume/reference: 22.73M
- One-month public movement: 4.92%
- Sector/category: Energy
Why DNN Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: Moderate Confidence.
- Current public directional label: bull. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Cameco vs. Denison: Which Uranium Stock Has an Edge Right Now? — Zacks
- Denison Mine (DNN) Reports Q2 Loss, Misses Revenue Estimates — Zacks
- Avino Silver (ASM) Meets Q2 Earnings Estimates — Zacks
- Integra Resources Corp. (ITRG) Misses Q2 Earnings and Revenue Estimates — Zacks
VKTX Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: Viking Therapeutics, Inc.. Market class: stock. Public bias: Bull. Public tier: A-List.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, which is in Phase II clinical trials for metabolic disorders and anemia; VK2735, a novel dual agonist of the glucagon-like peptide 1, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystr
- Latest public price/reference: $33.67
- Public market capitalization: $3.93B
- Recent public volume/reference: 1.67M
- One-month public movement: -9.76%
- Sector/category: Healthcare
Why VKTX Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: Moderate Confidence.
- Current public directional label: bull. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- VKTX Stock Edges Higher In August Ahead Of Early-Stage Obesity-Drug Data Release In Q3 — Stocktwits
- Viking Therapeutics Stock Is Down 66% From Its Peak. Here's What Comes Next. — Motley Fool
- Why Is Viking Therapeutics (VKTX) Up 2.3% Since Last Earnings Report? — Zacks
- Viking Therapeutics Has $502 Million in Cash and 1 Big Catalyst Left in 2026 -- Is That Enough? — Motley Fool
What The Public Data Shows
The public feed highlights ticker status, market class, directional bias, score, tier, confidence, company or project profile, public market references, and outside-source headlines. These fields support a deeper view of BLACKLEDGER's public research feed while keeping private methods undisclosed.
Why This Category Matters
The Buying section gives readers a focused path through the market: buying watch content for constructive candidates, selling watch content for defensive movement, investing content for higher-quality public watch names, and market trend notes for broader context.
Research-Only Notice
BLACKLEDGER content is market research only. There is no live execution signal, no recommendation to buy or sell, and no financial advice. Readers should perform their own due diligence and consult licensed professionals before making financial decisions.
Research-only. No execution signal. Not financial advice.